肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ASTRO临床实践指南：直肠癌的放射治疗

2020-10-20 美国放射治疗及肿瘤学会 Pract Radiat Oncol . 2020 Oct 20.

直肠癌

2020年10月，美国放射治疗及肿瘤学会(ASTRO)发布了直肠癌的放射治疗指南。本文主要回顾了局限性直肠癌放射治疗的适应证以及新辅助放疗的剂量的最新证据并提供相关指导建议。

中文标题：

2020 ASTRO临床实践指南：直肠癌的放射治疗

发布机构：

美国放射治疗及肿瘤学会

发布日期：

2020-10-20

简要介绍：

2020年10月，美国放射治疗及肿瘤学会(ASTRO)发布了直肠癌的放射治疗指南。本文主要回顾了局限性直肠癌放射治疗的适应证以及新辅助放疗的剂量的最新证据并提供相关指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ASTRO临床实践指南：直肠癌的放射治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2fb7c1c00200a052, title=2020 ASTRO临床实践指南：直肠癌的放射治疗, enTitle=, guiderFrom=Pract Radiat Oncol . 2020 Oct 20., authorId=0, author=, summary=2020年10月，美国放射治疗及肿瘤学会(ASTRO)发布了直肠癌的放射治疗指南。本文主要回顾了局限性直肠癌放射治疗的适应证以及新辅助放疗的剂量的最新证据并提供相关指导建议。, cover=https://img.medsci.cn/20201031/1604153008244_2020535.jpg, journalId=0, articlesId=null, associationId=9, associationName=美国放射治疗及肿瘤学会, associationIntro=美国放射治疗及肿瘤学会（ASTRO，American Society for Therapeutic Radiology Oncology）成立于1958年，其使命是：通过促进优质的患者监护推进放射肿瘤学的实践，为教育和专业发展提供机会，促进研究、传播研究结果并在快速发展的卫生保健环境中代表着放射肿瘤学。成立至今，ASTRO已拥有1万多名会员，包括放射肿瘤医师、放射肿瘤学护士、医用物理学家、放射治疗学家、剂量测定员和生物学家等等，是全球最大的放射肿瘤学组织之一。, copyright=0, guiderPublishedTime=Tue Oct 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年10月，美国放射治疗及肿瘤学会(ASTRO)发布了直肠癌的放射治疗指南。本文主要回顾了局限性直肠癌放射治疗的适应证以及新辅助放疗的剂量的最新证据并提供相关指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=748, tagName=直肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=748, guiderKeyword=直肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3736, appHits=132, showAppHits=0, pcHits=986, showPcHits=3604, likes=2, shares=8, comments=10, approvalStatus=1, publishedTime=Sat Oct 31 23:09:01 CST 2020, publishedTimeString=2020-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 22:03:35 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 01:24:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ASTRO临床实践指南：直肠癌的放射治疗.pdf)])
2020 ASTRO临床实践指南：直肠癌的放射治疗.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069472, encodeId=8a4a10694e2b4, content=优秀的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ed5697300, createdName=ms6000001024089719, createdTime=Fri Nov 12 08:29:56 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065332, encodeId=f1d01065332f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb545573242, createdName=ms4000000406966825, createdTime=Sat Oct 30 18:49:19 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052912, encodeId=eb1710529123f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8755472234, createdName=ms4000000253442559, createdTime=Sat Sep 18 22:50:12 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908475, encodeId=f3da9084e5f4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F54BA549E2472BFCACABAB4010C5ECB1/100, createdBy=3e102358265, createdName=zhaoyuzhang, createdTime=Wed Dec 16 10:02:44 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898836, encodeId=e26d89883667, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Thu Nov 12 23:07:47 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-11-12 ms6000001024089719

    优秀的平台

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069472, encodeId=8a4a10694e2b4, content=优秀的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ed5697300, createdName=ms6000001024089719, createdTime=Fri Nov 12 08:29:56 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065332, encodeId=f1d01065332f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb545573242, createdName=ms4000000406966825, createdTime=Sat Oct 30 18:49:19 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052912, encodeId=eb1710529123f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8755472234, createdName=ms4000000253442559, createdTime=Sat Sep 18 22:50:12 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908475, encodeId=f3da9084e5f4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F54BA549E2472BFCACABAB4010C5ECB1/100, createdBy=3e102358265, createdName=zhaoyuzhang, createdTime=Wed Dec 16 10:02:44 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898836, encodeId=e26d89883667, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Thu Nov 12 23:07:47 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-10-30 ms4000000406966825

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069472, encodeId=8a4a10694e2b4, content=优秀的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ed5697300, createdName=ms6000001024089719, createdTime=Fri Nov 12 08:29:56 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065332, encodeId=f1d01065332f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb545573242, createdName=ms4000000406966825, createdTime=Sat Oct 30 18:49:19 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052912, encodeId=eb1710529123f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8755472234, createdName=ms4000000253442559, createdTime=Sat Sep 18 22:50:12 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908475, encodeId=f3da9084e5f4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F54BA549E2472BFCACABAB4010C5ECB1/100, createdBy=3e102358265, createdName=zhaoyuzhang, createdTime=Wed Dec 16 10:02:44 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898836, encodeId=e26d89883667, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Thu Nov 12 23:07:47 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-09-18 ms4000000253442559

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069472, encodeId=8a4a10694e2b4, content=优秀的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ed5697300, createdName=ms6000001024089719, createdTime=Fri Nov 12 08:29:56 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065332, encodeId=f1d01065332f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb545573242, createdName=ms4000000406966825, createdTime=Sat Oct 30 18:49:19 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052912, encodeId=eb1710529123f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8755472234, createdName=ms4000000253442559, createdTime=Sat Sep 18 22:50:12 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908475, encodeId=f3da9084e5f4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F54BA549E2472BFCACABAB4010C5ECB1/100, createdBy=3e102358265, createdName=zhaoyuzhang, createdTime=Wed Dec 16 10:02:44 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898836, encodeId=e26d89883667, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Thu Nov 12 23:07:47 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2020-12-16 zhaoyuzhang

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069472, encodeId=8a4a10694e2b4, content=优秀的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ed5697300, createdName=ms6000001024089719, createdTime=Fri Nov 12 08:29:56 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065332, encodeId=f1d01065332f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb545573242, createdName=ms4000000406966825, createdTime=Sat Oct 30 18:49:19 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052912, encodeId=eb1710529123f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8755472234, createdName=ms4000000253442559, createdTime=Sat Sep 18 22:50:12 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908475, encodeId=f3da9084e5f4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F54BA549E2472BFCACABAB4010C5ECB1/100, createdBy=3e102358265, createdName=zhaoyuzhang, createdTime=Wed Dec 16 10:02:44 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898836, encodeId=e26d89883667, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Thu Nov 12 23:07:47 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2020-11-12 1361fc5d0em

    学习

    0

相关指南

2018 EARCS欧洲共识：直肠癌标准化机器人全肠系膜切除术

欧洲机器人结直肠外科学会(EARCS,European Academy for Robotic Colorectal Surgery) · 2018-11-29

2018 ACPGBI立场声明：直肠癌腹会阴联合切除术后会阴缺损封闭

大不列颠及爱尔兰肛肠协会(ACPGBI,Association of Coloproctology of Great Britain and Ireland) · 2018-08-28

2018 ESSO/ESCP/SIOG/ACS专家建议：老年直肠癌患者的个体化管理

欧洲肿瘤外科学会(ESSO,European Society of Surgical Oncology) · 2018-08-15

2017 SAR建议：直肠癌患者MRI检查

腹部放射学会(SAR,Society of Abdominal Radiology) · 2018-05-21

拓展阅读

2010 BSG 中高危人群结直肠癌筛查与监测指南

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2010-05-01

2010 结直肠癌肝转移诊断和综合治疗指南（V 2010）

中华医学会外科学分会 · 2010-06-01

2011 NICE 结直肠癌诊疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011NICE 结直肠癌高危人群（溃疡性结肠炎、克罗恩病、结直肠腺瘤患者）结肠镜监测指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-03-23

2011 规范结直肠癌术中缓释型氟尿嘧啶腹腔内化疗的专家共识

结直肠癌术中缓释型氟尿嘧啶腹腔内化疗共识专家组 · 2011-06-01

2011 EAES临床实践指南：腹腔镜腹膜外直肠癌手术

欧洲内镜外科协会(EAES,The European Association for Endoscopic Surgery) · 2011-06-24